Eugene Sullivan

Gene joined Insmed in March 2015 as Chief Medical and Scientific Officer and in June 2017 was appointed to the newly created role of Chief Product Strategy Officer. Gene has more than 20 years of experience with a focus on pulmonary and orphan diseases. He is a medical doctor trained in internal medicine, pulmonary medicine, and critical care medicine and practiced at the Cleveland Clinic from 1995 to 1999. From 1999 through 2006, Gene held several positions at the U.S. Food and Drug Administration, including Deputy Director of the Division of Pulmonary and Allergy Products. From 2007 through 2012, Gene was the Chief Medical Officer of United Therapeutics. In recent years, Gene was Vice President, Global Regulatory Affairs at AstraZeneca and consulted to companies, including Insmed, on clinical drug development and strategic regulatory matters. Gene graduated summa cum laude from the University of Maryland with a Bachelor of Science degree. He earned his medical degree from the University of Maryland, School of Medicine and conducted his internship and residency in Internal Medicine at the Medical College of Virginia. Gene completed his fellowship training in Pulmonary and Critical Care Medicine at the University of Colorado Health Sciences Center and received a Master of Pulmonary Vascular Disease from the University of Bologna in Italy.